Cite
MLA Citation
Sharon Cohen et al.. “Item‐level analysis of clinical measures in patients with early symptomatic Alzheimer's disease following treatment with high‐dose aducanumab in the phase 3 study EMERGE.” Alzheimer's & dementia, vol. 17, n.d., p. n/a. http://access.bl.uk/ark:/81055/vdc_100148192724.0x000029